BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 6753042)

  • 1. [Soluble fibrin monomer complexes in thromboembolism].
    Gryglik J
    Przegl Lek; 1982 Sep; 39(8):551-3. PubMed ID: 6753042
    [No Abstract]   [Full Text] [Related]  

  • 2. [A comprehensive laboratory evaluation of changes in the fibrinogen molecule in the diagnosis of acquired coagulopathy conditions].
    Siatkovskiĭ VA; Azarova LA; Vasilenko PL
    Lab Delo; 1989; (8):45-8. PubMed ID: 2477628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPR-phoresis, a novel approach to determining fibrin monomer and other macromolecular derivatives of fibrinogen and fibrin in blood.
    Shainoff JR; Urbanic DA; DiBello PM; Valenzuela V
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):87-92. PubMed ID: 8457658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The detection of soluble fibrin complexes by a haemagglutination test. Clinical applications (author's transl)].
    Soria J; Soria C; de Rodriguez S; Horellou MH; Samama M; Bilski-Pasquier G
    Nouv Presse Med; 1977 Dec; 6(43):4045-8. PubMed ID: 600751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between the plasma levels of soluble fibrin monomer and the formation of soluble fibrin monomer complex (SFMC)].
    Okajima K; Okabe H; Kumagai T; Yang WP; Maeda M; Miyagawa S; Watanabe E; Yoshimi K; Koga S; Takatsuki K
    Rinsho Byori; 1989 Apr; 37(4):411-5. PubMed ID: 2787429
    [No Abstract]   [Full Text] [Related]  

  • 6. [The fibrinogen-fibrin-fibrinolysis system in rheumatoid arthritis].
    Belitskaia GA; Palienko IA; Shevchenko LI; Fedorova NE
    Vrach Delo; 1989 Jan; (1):47-50. PubMed ID: 2718445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does coagulation have a causative role in eclampsia?
    Pritchard JA; Cunningham FG; Mason RA
    Perspect Nephrol Hypertens; 1976; 5():95-102. PubMed ID: 1005057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic degradation products from fibrinogen and fibrin with special respect to non-covalently associated complexes. Influence of fibrin crosslinking. Lysability and other properties.
    Feddersen C
    Scand J Clin Lab Invest Suppl; 1983; 166():1-60. PubMed ID: 6226084
    [No Abstract]   [Full Text] [Related]  

  • 9. Soluble fibrin as a molecular marker for a pre-thrombotic state: a mini-review.
    Nieuwenhuizen W
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):93-6. PubMed ID: 8457659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibrin/fibrinogen degradation products in the diagnosis of pulmonary thromboembolism].
    Ena IaM; Drannik GN; Konopleva LF
    Ter Arkh; 1985; 57(4):143-6. PubMed ID: 3892752
    [No Abstract]   [Full Text] [Related]  

  • 11. [The role of D2-E2 centers of interdomain binding of fibrin monomer during fibrinogen co-polymerization with an NH2-terminal disulfide knot of fibrin].
    Pozdniakova TM; Rybachuk VN; Ugarova TP
    Biokhimiia; 1987 Apr; 52(4):592-8. PubMed ID: 3593791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assessment of soluble fibrin in plasma by affinity chromatography--a comparative study with desAA-fibrin, desAABB-fibrin and fibrinogen.
    Thiel W; Delvos U; Müller-Berghaus G
    Thromb Haemost; 1985 Aug; 54(2):533-8. PubMed ID: 4082091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble fibrin-monomer complexes in normal pregnancy.
    Glavankova V; Doychinov A; Bachvarova V
    Zentralbl Gynakol; 1979; 101(17):1089-90. PubMed ID: 532438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contents of soluble fibrin monomer complexes and fibrinogen in the plasma and erythrocyte sedimentation rate].
    Kleniewski J
    Pol Tyg Lek; 1971 Apr; 26(17):627-9. PubMed ID: 5092297
    [No Abstract]   [Full Text] [Related]  

  • 15. [Soluble fibrin monomer complex (SFMC), soluble fibrin monomer (SFM)].
    Kawai Y
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():600-3. PubMed ID: 15658400
    [No Abstract]   [Full Text] [Related]  

  • 16. Formation of soluble fibrinogen-fibrin complex in liquid human plasma; reflexion of coagulation process in storage.
    Abe T; Kazama M; Tahara C; Miura Y; Yasuda J
    Jpn J Med Sci Biol; 1977 Apr; 30(2):91-9. PubMed ID: 916354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Content of soluble fibrin monomeric complexes, factor XIII and fibrin(ogen) degradation products in neonatal asphyxia].
    Suzuki S; Graeff H; Hafter R
    Arch Gynecol; 1979 Jul; 228(1-4):626-7. PubMed ID: 485520
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of the blood coagulation system after surgeries on abdominal aortic aneurysms].
    Nikul'nikov PI; Liksunov OV; Ratushniuk AV; Lugovs'koĭ EV; Kolesnikova IM; Lytvynova LM; Kostiuchenko OP; Chernyshenko TM; Hornyts'ka OV; Platonova TM
    Klin Khir; 2012 Sep; (9):32-6. PubMed ID: 23285650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fibrinogen degradation products, soluble fibrin and antithrombin III in toxic goiter patients].
    Panchenko VM; Salakhidinov Z; Khaĭkina MB
    Probl Endokrinol (Mosk); 1979; 25(1):11-5. PubMed ID: 581702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kinetic movement of fibrin monomer (soluble fibrin monomer complex. S.F.M.C.) in cases of asphyxiated newborn (author's transl)].
    Suzuki S
    Rinsho Ketsueki; 1979 Jul; 20(7):740-4. PubMed ID: 501998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.